Skip to main content
. 2020 Apr 7;6(4):e03719. doi: 10.1016/j.heliyon.2020.e03719

Figure 10.

Figure 10

Commercially available hydrogel implant for drug delivery (a) Cervidil® that contains 10 mg of dinoprostone in a hydrogel and, (b) SUPPRELIN® LA, a subcutaneous implant (Image courtesy: (a) Ferring Pharmaceuticals Inc. USA, (b) Endo Pharmaceuticals, USA.